Gray G A, Löffler B M, Clozel M
Pharma Division, Preclinical Research, Hoffmann-La Roche, Basel, Switzerland.
Am J Physiol. 1994 Mar;266(3 Pt 2):H959-66. doi: 10.1152/ajpheart.1994.266.3.H959.
The goal of this study was to characterize endothelin (ET) receptors mediating contraction of the rabbit saphenous vein. For this purpose, binding and functional studies were performed. Two receptor subtypes mediated contraction in response to ET-1. The first, responsible for 80-90% of maximal contraction, was stimulated with equal potency by ET-1, ET-3, and sarafotoxin S6c. The second, responsible for the remaining contraction, was stimulated more potently by ET-1 than by ET-3 and not by sarafotoxin S6c. The specific ETA receptor antagonist BQ-123 and the inhibitor of protein kinase C (PKC) Ro 31-8220 inhibited ET-1 contraction via the second but not the first receptor. In plasma membranes 125I-labeled ET-1 bound predominantly to a site with characteristics of ETA receptor, whereas 125I-ET-3 bound to two sites with characteristics of ETB receptor, one of high and one of low affinity. Comparison of binding affinity constants and 50% effective concentrations shows that the high-affinity ETB receptor corresponds to the receptor mediating the major part of contraction independently of PKC activation and ETA to the receptor mediating the minor part of contraction via a PKC-dependent mechanism.
本研究的目的是鉴定介导兔隐静脉收缩的内皮素(ET)受体。为此,进行了结合和功能研究。两种受体亚型介导对ET-1的收缩反应。第一种亚型介导80%-90%的最大收缩,对ET-1、ET-3和蛙皮素S6c的刺激效力相同。第二种亚型介导其余的收缩反应,对ET-1的刺激效力比对ET-3更强,且不受蛙皮素S6c的刺激。特异性ETA受体拮抗剂BQ-123和蛋白激酶C(PKC)抑制剂Ro 31-8220通过第二种而非第一种受体抑制ET-1收缩。在质膜中,125I标记的ET-1主要结合到具有ETA受体特征的位点,而125I-ET-3结合到具有ETB受体特征的两个位点,一个高亲和力位点和一个低亲和力位点。结合亲和力常数和50%有效浓度的比较表明,高亲和力ETB受体对应于独立于PKC激活介导大部分收缩的受体,而ETA对应于通过PKC依赖机制介导小部分收缩的受体。